These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26510395)

  • 21. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Feb; 45(2):190-8. PubMed ID: 25296530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.
    Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO; Eskild A; Vatten LJ
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement factor B activation in patients with preeclampsia.
    Velickovic I; Dalloul M; Wong KA; Bakare O; Schweis F; Garala M; Alam A; Medranda G; Lekovic J; Shuaib W; Tedjasukmana A; Little P; Hanono D; Wijetilaka R; Weedon J; Lin J; Toledano Rd; Zhang M
    J Reprod Immunol; 2015 Jun; 109():94-100. PubMed ID: 25604034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct First Trimester Cytokine Profiles for Gestational Hypertension and Preeclampsia.
    Tangerås LH; Austdal M; Skråstad RB; Salvesen KÅ; Austgulen R; Bathen TF; Iversen AC
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2478-85. PubMed ID: 26404486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
    Raijmakers MT; van Tits BJ; Hak-Lemmers HL; Roes EM; Steegers EA; Peters WH
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement component C4A and apolipoprotein A-I in plasmas as biomarkers of the severe, early-onset preeclampsia.
    Zhang H; Zhang Y; Yang F; Li L; Liu S; Xu Z; Wang J; Sun S
    Mol Biosyst; 2011 Aug; 7(8):2470-9. PubMed ID: 21677994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies.
    Mendilcioglu I; Trak B; Uner M; Umit S; Kucukosmanoglu M
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1044-8. PubMed ID: 15488119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the complement system in normal pregnancy and preeclampsia.
    Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
    Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
    Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
    Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.
    Taylor BD; Tang G; Ness RB; Olsen J; Hougaard DM; Skogstrand K; Roberts JM; Haggerty CL
    Pregnancy Hypertens; 2016 Jan; 6(1):72-8. PubMed ID: 26955776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery.
    Powers RW; Bodnar LM; Ness RB; Cooper KM; Gallaher MJ; Frank MP; Daftary AR; Roberts JM
    Am J Obstet Gynecol; 2006 Jan; 194(1):160. PubMed ID: 16389026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-four-hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre-eclampsia and gestational hypertension.
    Emery SP; Levine RJ; Qian C; Ewell MG; England LJ; Yu KF; Catalano PM;
    BJOG; 2005 Nov; 112(11):1479-85. PubMed ID: 16225566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.